Status:
COMPLETED
Patient-Centered Cancer Prevention In Chinese Americans
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
H. Pylori Infection
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This study will assess the efficacy, adoption, and impact of an integrated intervention to improve adherence to recommended stomach cancer prevention guidelines (H. pylori test-and-treat) for at-risk ...
Eligibility Criteria
Inclusion
- self identifies as Chinese American
- is an outpatient aged 21 years and older (adult)
- plans to continue to live in the region during the next 12 months;
- is willing to be randomized to either treatment or control groups
- has a confirmed diagnosis of H. pylori infection by at least one of the following methods: C-urea breath test, histology, rapid urease test or bacterial culture, fecal stool antigen test or other clinically approved H. pylori infection diagnostic test.
Exclusion
- advanced chronic disease that would not allow the patient to complete follow-up or attend visits;
- allergy to any of the study drugs;
- pregnancy or currently breastfeeding
- taking antibiotics or bismuth salts within 2 weeks before the study.
Key Trial Info
Start Date :
August 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03340454
Start Date
August 15 2018
End Date
June 15 2023
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016